Stay updated on Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi
Sign up to get notified when there's something new on the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page.

Latest updates to the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page
- Check3 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedPadua, Italy (35128) has been replaced with Padova, Italy (35128) for the Italy site entry.SummaryDifference0.0%

- Check32 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check46 days agoChange DetectedPublication entry updated to reflect a full 2026 Clin Lung Cancer article by the SAVANNAH study authors with a DOI. The previous 'Online ahead of print' citation was removed.SummaryDifference0.1%

- Check67 days agoChange DetectedThe updates add posted results and expand efficacy/safety endpoints (ORR, DoR, PFS, OS) with detailed time frames; they also remove multiple protocol-based biospecimen collection and exploratory analyses.SummaryDifference4%

- Check75 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page.